Gold Bond Medicated eczema relief

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Gold Bond Medicated eczema relief
Generic name: COLLOIDAL OATMEAL
Manufacturer: Chattem, Inc.
Product type: HUMAN OTC DRUG
SPL set ID: 52744c77-278f-40b1-a356-14ae4366389b
SPL ID: d5d5b990-2067-4a5b-ac84-7bfa12558f89
Version: 8
Effective date: 2026-01-14
Source export date: 2026-11-06
Source partition: 6
Source file: https://download.open.fda.gov/drug/label/drug-label-0006-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-11-06/10387d7618367cd955339e75d48af3d11f99f789153db05c529d9fad6eccc645/drug-label-0006-of-0014.json.zip
Source manifest SHA-256: 4a7570ba105b5a039a8e1c94a85e7f085b9047a8882a35a96bf1e4516c5ffc97
Import run: 20261108T063105Z
Imported at: 2026-11-08 07:18:49

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 11 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M016	openfda.application_number
brand name		Gold Bond Medicated eczema relief	openfda.brand_name
generic name		COLLOIDAL OATMEAL	openfda.generic_name
manufacturer name		Chattem, Inc.	openfda.manufacturer_name
ndc	package	41167-0567-1	openfda.package_ndc
ndc	product	41167-0567	openfda.product_ndc
ndc11	package	41167056701	derived:openfda.package_ndc
rxcui		1189915	openfda.rxcui
spl id		d5d5b990-2067-4a5b-ac84-7bfa12558f89	id
spl set id		52744c77-278f-40b1-a356-14ae4366389b	set_id
unii		8PI54V663Y	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings For external use only When using this produc t avoid contact with eyes Stop use and ask a doctor if condition worsens symptoms persist for more than 7 days or clear up and occur again within a few days Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center immediately.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.